Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    February 2018
  1. BOSCH DE, Farjah F, Wood DE, Schmidt RA, et al
    Regional lymph node sampling in lung carcinoma: a single institutional and national database comparison.
    Hum Pathol. 2018 Feb 12. pii: S0046-8177(18)30042.
    PubMed     Text format     Abstract available


  2. HAYASHI T, Takamochi K, Yanai Y, Mitani K, et al
    Non-small cell lung carcinoma with diffuse co-expression of thyroid transcription factor-1 and DeltaNp63/p40.
    Hum Pathol. 2018 Feb 1. pii: S0046-8177(18)30037.
    PubMed     Text format     Abstract available


    October 2017
  3. RIGHI A, Mancini I, Gambarotti M, Picci P, et al
    Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Hum Pathol. 2017;68:128-135.
    PubMed     Text format     Abstract available


  4. YEO MK, Choi SY, Seong IO, Suh KS, et al
    Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Hum Pathol. 2017;68:103-111.
    PubMed     Text format     Abstract available


    September 2017
  5. NELSON ER, Sharma R, Argani P, Cimino-Mathews A, et al
    Utility of Sox10 labeling in metastatic breast carcinomas.
    Hum Pathol. 2017;67:205-210.
    PubMed     Text format     Abstract available


  6. MARCHEVSKY AM, LeStang N, Hiroshima K, Pelosi G, et al
    The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
    Hum Pathol. 2017;67:160-168.
    PubMed     Text format     Abstract available


    August 2017
  7. TANAKA M, Kohashi K, Kushitani K, Yoshida M, et al
    Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions.
    Hum Pathol. 2017;66:177-182.
    PubMed     Text format     Abstract available


  8. FRYDENLUND N, Mahalingam M
    PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies.
    Hum Pathol. 2017;66:13-33.
    PubMed     Text format     Abstract available


  9. MOLINA-ROMERO C, Rangel-Escareno C, Ortega-Gomez A, Alanis-Funes GJ, et al
    Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.
    Hum Pathol. 2017;66:188-199.
    PubMed     Text format     Abstract available


    June 2017
  10. MATSUSHIMA J, Yazawa T, Suzuki M, Takahashi Y, et al
    Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and beta-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Hum Pathol. 2017;64:179-185.
    PubMed     Text format     Abstract available


    May 2017
  11. YVOREL V, Forest F, Karpathiou G, Peoc'h M, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung-reply.
    Hum Pathol. 2017;63:220-221.
    PubMed     Text format    


  12. MENGOLI MC, Bettelli S, Gasparri P, Bertolini F, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung.
    Hum Pathol. 2017;63:218-220.
    PubMed     Text format    


    April 2017
  13. KRENCZ I, Sebestyen A, Fabian K, Mark A, et al
    Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma.
    Hum Pathol. 2017;62:66-73.
    PubMed     Text format     Abstract available


    November 2016
  14. STEWART RL, O'Connor KL
    Integrin beta4 is a controversial target for non-small cell lung cancer-reply.
    Hum Pathol. 2016 Nov 2. pii: S0046-8177(16)30278.
    PubMed     Text format    


  15. CAO L, Xu J
    Integrin beta4 is a controversial target for non-small cell lung cancer.
    Hum Pathol. 2016 Nov 2. pii: S0046-8177(16)30277.
    PubMed     Text format    


    October 2016
  16. OWEN D, Sheffield BS, Ionescu D, Churg A, et al
    Loss of BRCA1-associated Protein 1 (BAP1) Expression Is Rare in Non-Small Cell Lung Cancer.
    Hum Pathol. 2016 Oct 28. pii: S0046-8177(16)30266.
    PubMed     Text format     Abstract available


    June 2016
  17. JIANG GY, Zhang XP, Zhang Y, Xu HT, et al
    Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.
    Hum Pathol. 2016 Jun 21. pii: S0046-8177(16)30116.
    PubMed     Text format     Abstract available


    May 2016
  18. GOTO A, Dobashi Y, Tsubochi H, Maeda D, et al
    MicroRNAs associated with increased AKT gene number in human lung carcinoma.
    Hum Pathol. 2016 May 14. pii: S0046-8177(16)30059.
    PubMed     Text format     Abstract available


  19. KOKUHO N, Terasaki Y, Urushiyama H, Terasaki M, et al
    Pulmonary mucosa-associated lymphoid tissue lymphoma associated with pulmonary sarcoidosis: a case report and literature review.
    Hum Pathol. 2016;51:57-63.
    PubMed     Text format     Abstract available


  20. BOLAND JM, Froemming AT, Wampfler JA, Maldonado F, et al
    Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.
    Hum Pathol. 2016;51:41-50.
    PubMed     Text format     Abstract available


    April 2016
  21. STEWART RL, West D, Wang C, Weiss HL, et al
    Elevated integrin alpha6beta4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
    Hum Pathol. 2016 Apr 20. pii: S0046-8177(16)30041.
    PubMed     Text format     Abstract available


  22. HAYASHI T, Kumasaka T, Mitani K, Okada Y, et al
    Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hum Pathol. 2016;50:34-42.
    PubMed     Text format     Abstract available


  23. SAITO H, Yamashita M, Ogasawara M, Yamada N, et al
    Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Hum Pathol. 2016;50:1-10.
    PubMed     Text format     Abstract available


    March 2016
  24. FOREST F, Yvorel V, Karpathiou G, Stachowicz ML, et al
    Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies.
    Hum Pathol. 2016;49:99-106.
    PubMed     Text format     Abstract available


  25. NWADEI IU, Lorentz A, Patil D, Dimarco MA, et al
    Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases.
    Hum Pathol. 2016;49:83-9.
    PubMed     Text format     Abstract available


  26. LAU KW, Aubry MC, Tan GS, Lim CH, et al
    Ciliated muconodular papillary tumor: a solitary peripheral lung nodule in a teenage girl.
    Hum Pathol. 2016;49:22-6.
    PubMed     Text format     Abstract available


    February 2016
  27. YE B, Cappel J, Findeis-Hosey J, McMahon L, et al
    hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
    Hum Pathol. 2016;48:142-7.
    PubMed     Text format     Abstract available


    January 2016
  28. ROOPER LM, Nikolskaia O, Carter J, Ning Y, et al
    A Single EBUS-TBNA Procedure Can Support a Large Panel of Immunohistochemical Stains, Specific Diagnostic Subtyping, and Multiple Gene Analyses in the Majority of Non-Small Cell Lung Cancer Cases.
    Hum Pathol. 2016 Jan 18. pii: S0046-8177(16)00027.
    PubMed     Text format     Abstract available


  29. FISHBEIN GA, Grimes BS, Xian RR, Lee JM, et al
    Primary salivary duct carcinoma of the lung, mucin-rich variant.
    Hum Pathol. 2016;47:150-6.
    PubMed     Text format     Abstract available


  30. DAVIDSON B, Stavnes HT, Hellesylt E, Hager T, et al
    MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
    Hum Pathol. 2016;47:104-8.
    PubMed     Text format     Abstract available


    December 2015
  31. CECCHINI MJ, Ishak CA, Passos DT, Warner A, et al
    Loss of the retinoblastoma tumor suppressor correlates with improved outcome in patients with lung adenocarcinoma treated with surgery and chemotherapy.
    Hum Pathol. 2015;46:1922-34.
    PubMed     Text format     Abstract available


  32. WU Z, Bai F, Fan L, Pang W, et al
    Coexpression of receptor tyrosine kinase AXL and EGFR in human primary lung adenocarcinomas.
    Hum Pathol. 2015;46:1935-44.
    PubMed     Text format     Abstract available


    November 2015
  33. MCGREGOR SM, Dunning R, Hyjek E, Vigneswaran W, et al
    BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
    Hum Pathol. 2015;46:1670-8.
    PubMed     Text format     Abstract available


  34. CHANG SY, Keeney M, Law M, Donovan J, et al
    Detection of human papillomavirus in non-small cell carcinoma of the lung.
    Hum Pathol. 2015;46:1592-7.
    PubMed     Text format     Abstract available


  35. ADACHI K, Miki Y, Saito R, Hata S, et al
    Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis.
    Hum Pathol. 2015;46:1685-93.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: